By Ian Walker

 

GSK PLC said Monday that it has appointed Julie Brown as its new chief financial officer, replacing Iain Mackay, from May 2023.

The pharmaceutical giant said Ms. Brown will join the company in April and become CFO on May 1.

Ms. Brown is currently chief operating and financial officer of Burberry Group PLC. She has also held roles at AstraZeneca PLC and Smith & Nephew PLC.

Earlier Monday Roche Holding AG said Ms. Brown was stepping down from its board with immediate effect as she had accepted a role at another pharmaceutical company.

 

Write to Ian Walker at ian.walker@wsj.com

 

(END) Dow Jones Newswires

September 26, 2022 02:33 ET (06:33 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Astrazeneca (LSE:AZN)
Gráfica de Acción Histórica
De Nov 2022 a Dic 2022 Haga Click aquí para más Gráficas Astrazeneca.
Astrazeneca (LSE:AZN)
Gráfica de Acción Histórica
De Dic 2021 a Dic 2022 Haga Click aquí para más Gráficas Astrazeneca.